15 January 2013 - Specialist pharmaceutical company SciClone Pharmaceuticals Inc (NASDAQ:SCLN) revealed on Monday the election of Simon Li to its board of directors.

Most recently, Li has served as the global officer and member of the Executive Committee of Medtronic as well as president of Greater China and chair of the board of Medtronic-Weigao JV.

Prior to Medtronic, Li was employed as the international vice president, North Asia / New Business Development, Asia Pacific / Strategic Medical Affairs, Asia Pacific with Johnson & Johnson Medical, China, including international vice president, North Asia, managing director, China and Hong Kong, and managing director, China.

Previously, Li worked as president and chief operating officer of the ConvaTec business with Bristol-Myers Squibb in Hong Kong as well as general manager of the pharmaceutical distributor YC Woo & Co Ltd in Hong Kong.